The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The neurofibromatosis type 1 gene encodes a protein related to GAP
Abstract
cDNA walking and sequencing have extended the open reading frame for the neurofibromatosis type 1 gene (NF1). The new sequence now predicts 2485 amino acids of the NF1 peptide. A 360 residue region of the new peptide shows significant similarity to the known catalytic domains of both human and bovine GAP (GTPase activating protein). A much broader region, centered around this same 360 amino acid sequence, is strikingly similar to the yeast IRA1 product, which has a similar amino acid sequence and functional homology to mammalian GAP. This evidence suggests that NF1 encodes a cytoplasmic GAP-like protein that may be involved in the control of cell growth by interacting with proteins such as the RAS gene product. Mapping of the cDNA clones has confirmed that NF1 spans a t(1;17) translocation mutation and that three active genes lie within an intron of NF1, but in opposite orientation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“KRAS proteins primarily bind to guanosine diphosphate (GDP) and are in an inactive conformation maintained by intrinsic guanosine triphosphate (GTP) hydrolytic activity.”
From Targeting KRAS mutant cancers: from druggable therapy to drug resistance (2022) · cites this paper as [9]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512
A simple method for displaying the hydropathic character of a protein
Kyte, J., & Doolittle, R. F. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90515-0 · Cited by 22,927
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90381-6 · Cited by 4,952
Screening λgt Recombinant Clones by Hybridization to Single Plaques in Situ
Benton, W. D., & Davis, R. W. (1977) · Science · doi:10.1126/science.322279 · Cited by 4,520
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,259
[5] Rapid and sensitive sequence comparison with FASTP and FASTA
Pearson, W. R. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)83007-v · Cited by 1,934
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H. M., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J. M., Mitchell, A. L., et al. (1990) · Science · doi:10.1126/science.2134734 · Cited by 1,478
Research works printed but not linked: 1
- Stumpf, 1987, Neurofibromatosis, Arch. Neurol., 45, 575
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Lungu, B., Baican, S., Badarau, Z., & Lungu, Z. (2014) · Archive of Clinical Cases · doi:10.22551/2014.02.0102.10014 · Cited by 2
“Neurofibromin, the gene product, is ubiquitously expressed at high levels in the nervous system and functions as a tumor suppressor [10, 22-24].”
Takakura, K., Kajihara, M., Sasaki, S., Nagano, T., Ohta, A., Ikegami, M., Eto, K., Kashiwagi, H., Yanaga, K. K., Arihiro, S., et al. (2011) · Case Reports in Gastroenterology · doi:10.1159/000329171 · Cited by 2
Using Genomic Data to Make Indirect (and Unauthorized) Estimates of Disease Risk
Nyholt, D. R. (2012) · Public Health Genomics · doi:10.1159/000336546 · Cited by 2
Yi, H., Kim, S. H., Kim, J., Bae, E.-J., Hong, S., Park, I. B., Kim, Y. J., & Lee, S. (2011) · Endocrinology and Metabolism · doi:10.3803/enm.2011.26.2.177 · Cited by 2
Cardiac Imaging in RASopathies/Mitogen Activated Protein Kinase Syndromes
Gravino, R., & Pacileo, G. (2014) · Cardiogenetics · doi:10.4081/cardiogenetics.2014.2198 · Cited by 2
Suzuki, H., Takahashi, K., & Shibahara, S. (1995) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.175.225 · Cited by 2
Low frequency of NF1 gene mutations in malignant gliomas
Finocchiaro, G., Tenan, M., Colombo, B. M., Cajola, L., Broggi, G., & Pollo, B. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80329-6 · Cited by 2
Solga, A. C., & Gutmann, D. H. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_22 · Cited by 2
RASopathies et cancers de l’enfant
Strullu, M., Caye‐Eude, A., Verloès, A., & Cavé, H. (2015) · Revue d Oncologie Hématologie Pédiatrique · doi:10.1016/j.oncohp.2015.07.004 · Cited by 2
Kitade, T., Sonoyama, T., Wakasa, M., Yamasaki, S., Sai, S., & Ishihara, Y. (2012) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.73.3003 · Cited by 2
Murata, A., Amano, R., Kimura, K., Yamazoe, S., Ohira, G., Nishio, K., & Hirakawa, K. (2016) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.2015.0068 · Cited by 2
Saulino, A. M., Camonis, J., Wigler, M. H., Collins, F. S., Andersen, L. B., Ballester, R., Chang, E. R., & Gutmann, D. H. (2012) · Cited by 2
Brain tumors associated with neurofibromatosis
Asthagiri, A. R., Warren, K. E., & Lonser, R. R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-443-06967-3.00030-2 · Cited by 2
Immunoglobulin A nephropathy in a patient with neurofibromatosis type 1
Rhee, H., Kim, S., Lee, W., Jeon, H., Kim, D. W., Ye, B. M., Kim, H. J., Kim, M. J., Kim, S. R., Kim, I. Y., et al. (2021) · Medicine · doi:10.1097/md.0000000000027572 · Cited by 2
Benign Peripheral Nerve Sheath Tumors: Neurofibromas, Schwannomas, and Perineuriomas
Sandberg, A. A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_1 · Cited by 2
Ferner, R. E. (2011) · Springer eBooks · doi:10.1007/978-0-85729-629-0_1 · Cited by 2
Weinberg, J. M., Barbagallo, J. S., Kolodzieh, M. S., & Silverberg, N. B. (2003) · Current Problems in Dermatology · doi:10.1016/s1040-0486(03)70008-8 · Cited by 2
Oncogenes in Renal Cell Carcinoma
Yoshida, O., Habuchi, T., Kinoshita, H., & Ogawa, O. (1995) · Springer eBooks · doi:10.1007/978-1-4612-2536-2_3 · Cited by 2
Nur-e-Kamal, M. S. A. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00082-9 · Cited by 2
Hazan, F., Gürsoy, S., Ünalp, A., Yılmaz, Ü., Demirağ, B., Köker, S. A., Özyılmaz, B., Erdoğan, K. M., Kalenderer, Ö., Erkuş, S., et al. (2021) · Neurological Sciences · doi:10.1007/s10072-020-04988-0 · Cited by 2
Diagnosis of neurofibromatosis type 1 using RFLPs tightly linked to gene
Vivarelli, R., Bartalani, G., Berardi, A., Calistri, L., Balestri, P., & Fois, A. (1993) · Child s Nervous System · doi:10.1007/bf00272264 · Cited by 2
Clinical and Molecular Neurogenetics in Neurosurgery
Harding, A. E. (1993) · Advances and technical standards in neurosurgery · doi:10.1007/978-3-7091-6912-4_3 · Cited by 2
Serum mitogenic activity on in vitro glial cells in Neurofibromatosis type 1
Caronti, B., Buttarelli, F. R., Giustini, S., Calderaro, C., Calandriello, L., Calvieri, S., & Palladini, G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00016-x · Cited by 2
Murgia, A., Anglani, F., Vinanzi, C., Polli, R., Basso, G., Perilongo, G., Giangaspero, F., & Zacchello, F. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10078-8 · Cited by 2
Hotta, T., Asai, K., Takeda, N., Yoshizumi, H., Tatematsu, A., Nakanishi, K., Ekşioğlu, Y. Z., Isobe, I., & Kato, T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13637.x · Cited by 2
NISHIJIMA, K., Itoh, H., Kurosaka, Y., Takegawa, S., Kiriyama, M., & Kojima, Y. (2003) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.64.1920 · Cited by 2
MOLECULAR PATHOGENESIS AND MANAGEMENT OF GLIOMAS
Kyritsis, A. P., Saya, H., & Levin, V. A. (1993) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(25)00201-1 · Cited by 2
Neurofibromin is essential to maintain metabolic function and sustain life in the adult mousePreprint
Turner, A. N., Johnson, M. S., Brosius, S. N., Yoder, B. S., Yang, K., Yang, Q., Moore, J. F., Yang, Q., Moore, J. F., Sharer, J. D., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/324061 · Cited by 2
“22 Supplementary Materials Supplemental Tables (1-4); Supplemental Figures (1-10)”
BackgroundTheos, A. J., & Korf, B. R. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.01514-x · Cited by 2
Roos, K. L. (1992) · Ear Nose & Throat Journal · doi:10.1177/014556139207101013 · Cited by 2
Cellular and Molecular Pathology of Adrenocortical Carcinoma
Else, T. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_9 · Cited by 1
“Of interest, NF1 ,t he gene mutated in neurofibromatosis type 1, encodes a RASGAP [ 51 ].”
BackgroundSelumetinib in Adult Neurofibromatosis 1 with Plexiform Neurofibroma
Yuen, C., Chu, E., O’Connell, R., Sun, B. K., Vyas, R. M., Zheng, M., Elliott, E., & Xiao, C. (2025) · Pharmaceuticals · doi:10.3390/ph18071039 · Cited by 1
Loponen, N., Kallionpää, R. A., Ylä‐Outinen, H., Valtanen, M., Auranen, K. J., Järveläinen, H., Peltonen, S. A., & Peltonen, J. T. K. (2025) · Genetics in Medicine · doi:10.1016/j.gim.2025.101571 · Cited by 1
Doherty, M. A., Grell, K., Hove, H. D., Handrup, M. M., Østergaard, J. R., Krøyer, A., Nielsen, T. T., Hjalgrim, H., Mulvihill, J. J., Wohlfahrt, J., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03316-7 · Cited by 1
“NF1 results from gene deletions or pathogenic variants located on chromosome 17, causing defects in the tumour suppressor protein neuro fi bromin, thereby grounding NF1 as a tumour predisposition syndrome [6].”
Microenvironmental TGF-β is an early driver of NF1-associated tumor formation
Power, A., Stierli, S., Harford‐Wright, E., Mòdol‐Caballero, G., Lloyd, E., Kouloulia, S., Casal, G., Yuan, N., Krasinska, L., Bouricha, O., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116822 · Cited by 1
Genetic and non-genetic factors influencing phenotypic variability in neurofibromatosis type 1
Clissa, P. B., & Sanabani, S. S. (2026) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-026-04334-1 · Cited by 1
Neurofibromatosis Type 1: Future Directions (Where Do We Go from Here?)
Parada, L. F. (2012) · Springer eBooks · doi:10.1007/978-3-642-32864-0_44 · Cited by 1
“Indeed the large encoded protein, neurofibromin, was found to contain functional Ras GTPase activating domain (GAP), leading to the model that loss of NF1 function would result in loss of negative regulation of Ras protein (Bollag et al. 1996; Martin et al. 1990; Xu et al. 1990).”
BackgroundThe neurofibromatoses and related disorders
Ferner, R. E. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.014 · Cited by 1
A Model for the Molecular Pathogenesis of Astrocytic Gliomas
Wiestler, O. D., & von Deimling, A. (1996) · Springer eBooks · doi:10.1007/978-4-431-66887-9_18 · Cited by 1
Pascual-Castroviejo, I., Taboada-Barajas, J., & Aguilar-Rebolledo, F. (2005) · Plasticidad y Restauración Neurológica · Cited by 1
Han, C., Chen, J., Gao, S., & Duan, L. (2012) · Cited by 1
Reuter, C. W. M., Morgan, M. A., & Bergmann, L. (2001) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-18156-6_18 · Cited by 1
Molecular Pathogenesis of Human Cancer
Coleman, W. B., & Tsongalis, G. J. (2006) · Humana Press eBooks · doi:10.1385/1-59259-928-1:349 · Cited by 1
Maeda, T., Akagi, J., Ohchi, T., Doi, K., Ogata, K., & Suzuki, S. (2011) · 日本消化器外科学会雑誌 · doi:10.5833/jjgs.44.706 · Cited by 1
Mizukoshi, W., Kozawa, E., Kuramochi, A., Uchino, A., & Kimura, F. (2008) · The Neuroradiology Journal · doi:10.1177/197140090802100615 · Cited by 1
Myelodysplastic/myeloproliferative neoplasms
Choi, J. K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781292.014 · Cited by 1
Surgery for Malignant Peripheral Nerve Sheath Tumors
Maniker, A. H., Gupta, G., & Guha, A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00248-3 · Cited by 1
Kucherlapati, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00004-5 · Cited by 1
Erickson, J. W., Antonyak, M. A., Fuji, R. N., & Cerione, R. A. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_18 · Cited by 1
Huson, S., & Korf, B. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00128-2 · Cited by 1
Child plexiform neurofibroma of the lumbar region. Case report
Kessely, Y. C., Aouami, A., Ouambi, L.-I. O., al., T. G. F. E., Njesada, N. S., Nute, J. J., Abbassi, A., Adam, Y., Bray, K., Assi, C., et al. (2021) · Interdisciplinary Neurosurgery · doi:10.1016/j.inat.2021.101362 · Cited by 1
Clinical and molecular features of neurofibromatosis types 1 and 2: a review of the literature
Polatova, D., Савкин, А. В., Асамединов, Н. К., Davletov, R. R., Нуржабов, А. И., & Насиров, С. К. (2022) · Bone and soft tissue sarcomas tumors of the skin · doi:10.17650/2219-4614-2022-14-3-33-41 · Cited by 1
Pregnancy and the Risk for Cancer in Neurofibromatosis 1
Kallionpää, R. A., Määttänen, J., Leppävirta, J., Peltonen, S. A., & Peltonen, J. T. K. (2025) · Genes Chromosomes and Cancer · doi:10.1002/gcc.70017 · Cited by 1
Kallionpää, R. A., Martikkala, E., Haapaniemi, P., Karppinen, S., Riihilä, P., Rokka, A., Leivo, I. V. V., Pihlajaniemi, T. A., Peltonen, S. A., & Peltonen, J. T. K. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03055-9 · Cited by 1
Genetics in learning and memory
Wang, Y., Dubnau, J., Tully, T., & Zhong, Y. (2007) · Elsevier eBooks · doi:10.1016/b978-012372540-0/50004-2 · Cited by 1
Genetische Grundlagen der Kanzerogenese
Bartram, C. R. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_4 · Cited by 2
A case of squamous cell carcinoma of the lower gingiva complicated by von Recklinghausen’s disease
Rin, S., YAMASHITA, T., Ueda, M., Asaka, Y., YAJIMA, K., & FUJITA, M. (2011) · Japanese Journal of Oral & Maxillofacial Surgery · doi:10.5794/jjoms.57.309 · Cited by 1
PRIMARY MALIGNANT MELANOMA OF THE GASTROINTESTINAL TRACT: REPORT OF TWO CASES
Safaei, A., Tabib, S. M., Mohammadreza, F., Shahryari, J., & Mohamad, B. (2014) · Iranian journal of pathology · Cited by 1
Okumura, N., Tokuyama, Y., YAMAGUCHI, K., OSADA, S., Iwata, H., Hirose, Y., & Yoshida, K. (2011) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.72.1297 · Cited by 1
Molecular Biology of Human Brain Tumors
Coluccia, D., Weeks, A., Fandino, J., Schneider, C., Smith, C. A., & Rutka, J. T. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_35 · Cited by 1
A Case of Neurofibromatosis Type 1 with Colonic and Small Intestinal Cancer
KOSHIMA, K., TSUBOUCHI, M., & Fukuura, T. (2015) · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · doi:10.3919/jjsa.76.1719 · Cited by 1
Nile, A. H. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xdt3-hc64 · Cited by 1
CEREBROVASCULAR MANIFESTATIONS OF NEUROFIBROMATOSIS
Nedeltchev, K., & Mattle, H. P. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544897.031 · Cited by 1
Chapter 5 Molecular biology of prostate cancer
Gao, X., & Honn, K. V. (1999) · Advances in oncobiology/Advances in oncobiology (Print) · doi:10.1016/s1569-254x(99)80006-5 · Cited by 1
Pollack, I. F. (2010) · Pediatric Hematology and Oncology · doi:10.1002/9781444315134.ch2 · Cited by 1
Chapter 26. Regulation of the ras GTPase Cycle
Bollag, G. E., Haubruck, H., & McCormick, F. P. (1991) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61213-0 · Cited by 1
Kitano, Y., Saito, K., Okamoto, E., & Hashizume, K. (1994) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)90082-5 · Cited by 1
Genes associated with tumor suppression and growth control in the human nervous system
Seizinger, B. R. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00554790 · Cited by 1
Elmslie, F. (1998) · European Journal of Paediatric Neurology · doi:10.1016/s1090-3798(98)80033-0 · Cited by 1
Biochemie und Molekularbiologie 1990
Sperling, K. (1991) · Nachrichten aus Chemie Technik und Laboratorium · doi:10.1002/nadc.19910390209 · Cited by 1
Wood, L., & Whittaker, P. A. (1994) · Gene · doi:10.1016/0378-1119(94)90814-1 · Cited by 1
Biochemical Study of Cells Cultured from a Patient with Tuberous Sclerosis
Takahashi, T., Monica‐Masuda, L., Ito, S., Katsumoto, T., Ishibashi, Y., & Onodera, K. (1992) · The Journal of Dermatology · doi:10.1111/j.1346-8138.1992.tb03804.x · Cited by 1
Growth of only highly tumorigenic cell lines is inhibited by EAP, a human placental fraction
Klein, J. L., Chiodino, C., & Yamasaki, H. (1993) · Cancer Letters · doi:10.1016/0304-3835(93)90079-o · Cited by 1
Stephenson, C., Brivet, M., Gautier, M., Deschatrette, J., GITZELMANN, R., & Karran, P. (1991) · Biochemical Genetics · doi:10.1007/bf00554207 · Cited by 1
“The structure of the NF-1 gene is complex and its product exhibits considerable homology to GAP, a GTPaseactivating protein which interacts with the cellular Ras protein (Xu et al., 1990).”
BackgroundAnalysis of Ras Structure and Dynamics by Nuclear Magnetic Resonance
Campbell-Burk, S., & Aken, T. E. V. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78267-1_15 · Cited by 1
Koivunen, J. P. (2003) · Cited by 1
Sunumu, O., Bozdağ, K. E., Altun, Y., & Ermete, M. (2004) · Cited by 1
NAKAYAMA, J., Urabe, A., Kohei, O., & Hori, Y. (1994) · The Nishinihon Journal of Dermatology · doi:10.2336/nishinihonhifu.56.262 · Cited by 1
Nonrhabdomyosarcomas and Other Soft Tissue Tumors
Davis, I. J., Pérez‐Atayde, A. R., & Fisher, D. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3431-5.00020-0 · Cited by 1
A Transgenic Model to Study the Role of Oncogenes and Tumour Suppressor Genes in T-Cell Lymphoma
Blyth, K. (1996) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Opticusgliome bei Kindern mit Neurofibromatose Typ 1: Eine Langzeit-Untersuchung an 38 Patienten
Thimm, A. (2012) · Univ. Duesseldorf: Duesseldorfer Dokumenten- und Publikationsserver · Cited by 1
Ly, S. H. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Cortner, J., Woude, S. V., & Woude, G. F. V. (1997) · Advances in veterinary medicine · doi:10.1016/s0065-3519(97)80004-3 · Cited by 1
Berg, B. O. (2008) · Elsevier eBooks · doi:10.1016/b978-044306707-5.50014-6 · Cited by 1
Trump, B. F. (1991) · Toxicologic Pathology · doi:10.1177/019262339101900409 · Cited by 1
Chang, J., Kobayashi, M., Wang, D. Z. ‐., Maruta, H., & Iwashita, S. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20862.x · Cited by 1
The Interplay Between Tumor Suppressor Genes and Oncogenes in Tumorigenesis
Holland, E. C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-313-2_6 · Cited by 1
Bernards, A., & McClatchey, A. I. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-230-2_11 · Cited by 1
Molecular Events in the Development and Progression of Medullary Thyroid Cancer and Pheochromocytoma
Moley, J. F. (1996) · Medical intelligence unit · doi:10.1007/978-3-662-21948-5_9 · Cited by 1
Neurofibromatosis (NF) types 1 and 2
Huson, S. (1996) · Springer eBooks · doi:10.1007/978-1-4899-4501-3_5
Bos, J. L., & Burgering, B. M. T. (1995) · Advances in genome biology · doi:10.1016/s1067-5701(06)80007-0
Genetische Grundlagen der Tumor- und Metastasensuppression bei Drosophila und Mensch
Gateff, E. A. (1991) · Springer eBooks · doi:10.1007/978-3-642-84560-4_12
Rigou, P., Faye, A., & Poyet, J. (2009) · Springer eBooks · doi:10.1007/978-90-481-3415-1_12
“Interestingly, microdeleted patients usually exhibit numerous and precocious neurofibromas and appear to have a more severe malignant tumors burden, both NF1 associated and those not known to be associated with NF1 (Kayes et al. 1994; Wu et al. 1995, 1997; Cnossen et al. 1997; Leppig et al. 1997; Tonsgard et al. 1997;…”
BackgroundNeurofibromatosis - Diagnostic Assessment
Costa, S., Tojal, R., & Valverde, A. (2012) · InTech eBooks · doi:10.5772/28503
“Sequence analysis of the full length NF1 gene cDNA revealed a portion that codes for a 360 amino acid peptide with structural and functional similarities to some guanosine triphosphatase activating proteins (GAP) in other mammalian and yeast cells (Xu et al 1995).”
BackgroundCloning and characterization of RIP1, an effector of Ral
Park, S. H. (1996) · DSpace@MIT (Massachusetts Institute of Technology)
Wilson, G. N. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545054.005
Proviral tagging: A strategy using retroviruses to identify oncogenes
Möröy, T., Zörnig, M., & Schmidt, T. (2001) · Perspectives in medical virology · doi:10.1016/s0168-7069(01)05012-1
Metadata
- Authors
- Xu, G., O'Connell, P., Viskochil, D., Cawthon, R., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., White, R., & Weiss, R.
- Affiliations
- Howard Hughes Medical Institute (US)
- University of Utah (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1990-08
- Volume
- 62
- Issue
- 3
- Pages
- 599-608
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2159096148
- Cited by
- 1,095
- References
- 42
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 19 · 2023: 19 · 2022: 22 · 2021: 22 · 2020: 22 · 2019: 18 · 2018: 22 · 2017: 17 · 2016: 19 · 2015: 21 · 2014: 24 · 2013: 24 · 2012: 45
- FWCI
- 70.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- U.S. Department of Energy
- Topics
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- neurofibromatosis type 1, NF1 gene, GTPase-activating protein, Ras, open reading frames, cDNA cloning, cell growth regulation, protein homology
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cattle, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 17, Cloning, Molecular, Genes, Humans, Information Systems, Molecular Sequence Data, Neurofibromatosis 1, Proteins, Sequence Homology, Nucleic Acid, Translocation, Genetic, Oligonucleotide Probes, Gene Library, Polymerase Chain Reaction, GTPase-Activating Proteins, ras GTPase-Activating Proteins, Neurofibromin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review